3151

Vital KSK Holdings Co., Ltd.

株式会社バイタルケーエスケー・ホールディングス
Healthcare · Medical Distribution
Vital KSK Holdings, Inc. engages in the wholesale and retail sale of pharmaceutical products in Japan. The company sells poisonous or deleterious substances, narcotics, quasi-drugs, medical equipment and devices, sanitary materials, hygiene goods, nursing care products, and beverages; and test reagents, agricultural chemicals, epidemiological agents and materials, industrial chemicals, veterinary drugs, poisonous and deleterious substances, paints, pigments, dyes, regenerative medicine products, and other chemicals, as well as well as chemicals for scientific use. It is also involved in the operation pharmacies; provision of medical management consulting services for medical institutions such as hospitals, nursing care providers, and local governments; wholesale of agricultural chemicals and agricultural materials; nursing care-related business; rental and sales of welfare equipment and home modification; general freight vehicle transportation activities; and insurance agency, real estate management, and parking lot operation businesses.Vital KSK Holdings, Inc. was incorporated in 2009 and is headquartered in Setagaya, Japan.
← Companies
Price
¥1,640
Market Cap
¥79.3B
Ent. Value
¥63.0B
Net Cash
¥16.4B
Shares Out.
48.4M
P / E
11.0×
EV / EBIT
11.0×
P / Book
0.75×
P / NCAV
N/M
Div. Yield
2.74%
Financials
Metric FY 2024
EDINET ↗ 		FY 2023
EDINET ↗ 		FY 2022
EDINET ↗ 		FY 2021
EDINET ↗
Net Sales ¥600.4B ¥587.5B ¥579.8B ¥577.2B
Cost of Sales ¥551.2B ¥539.2B ¥534.8B ¥533.3B
Gross Profit ¥49.2B ¥48.3B ¥45.0B ¥44.0B
SG&A ¥43.5B ¥42.7B ¥42.5B ¥41.0B
Operating Income ¥5.7B ¥5.6B ¥2.5B ¥2.9B
Non-Operating Income ¥1.5B ¥1.4B ¥3.7B ¥3.1B
Dividend Income ¥702M ¥699M ¥751M ¥804M
Interest Income ¥34M ¥32M ¥31M ¥49M
Non-Operating Expenses ¥207M ¥378M ¥192M ¥212M
Interest Expense ¥81M ¥103M ¥96M ¥99M
Ordinary Income ¥7.0B ¥6.6B ¥6.0B ¥5.8B
Pre-tax Income ¥10.7B ¥8.7B ¥8.1B ¥7.6B
Income Taxes ¥3.3B ¥2.7B ¥3.2B ¥2.8B
Current Tax ¥2.9B ¥3.0B ¥3.2B ¥2.6B
Deferred Tax ¥379M ¥-238M ¥-7M ¥191M
Net Income (owners) ¥7.3B ¥5.8B ¥4.8B ¥4.8B
Minority Interest ¥93M ¥100M ¥102M ¥110M
Comprehensive Income ¥5.9B ¥9.8B ¥2.5B ¥-1.7B
EBITDA ¥9.5B ¥8.9B ¥5.8B ¥6.1B
Goodwill Amort. (J-GAAP) ¥128M ¥137M ¥343M ¥343M
EPS ¥149.02 ¥115.03 ¥92.69 ¥87.88
Shares Outstanding 48.4M 50.3M 51.9M 53.4M
Shares Issued (total) 51.9M 51.9M 61.2M 61.2M
Treasury Shares 3.5M 1.6M 9.3M 7.9M